Obstructive sleep apnea, circulating microRNAs, and risk of cardiovascular disease

被引:1
|
作者
Lisan, Q. [1 ,2 ]
Marques-Vidal, P. [3 ,4 ]
Hausler, N. [3 ,4 ]
Danchin, N. [5 ]
Boutouyrie, P. [6 ]
Asselin, A. [1 ]
Jouven, X. [1 ]
Heinzer, R. [4 ,7 ]
Empana, J. P. [1 ]
机构
[1] Univ Paris Cite, Paris Cardiovasc Res Ctr, Team Integrat Epidemiol Cardiovasc Dis, INSERM,UMR S970, Paris, France
[2] Foch Hosp, Dept Head & Neck Surg, F-92150 Suresnes, France
[3] Lausanne Univ Hosp CHUV, Dept Med, Internal Med, Lausanne, Switzerland
[4] Univ Lausanne, Lausanne, Switzerland
[5] Prevent & Clin Invest Ctr, Paris, France
[6] Univ Paris Cite, Paris Cardiovasc Res Ctr, Team Cellular Mol & Physiol Mech Heart Failure, INSERM,UMR S970, Paris, France
[7] Lausanne Univ Hosp CHUV, Ctr Invest & Res Sleep CIRS, Lausanne, Switzerland
关键词
Sleep apnea; microRNA; Cardiovascular disease;
D O I
10.1016/j.sleep.2023.06.006
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: while obstructive sleep apnea is strongly associated with incident cardiovascular diseases (CVD), the underlying mechanisms remain to be elucidated. This study aimed to compare the patterns of microRNAs expression between OSA and control patients with and without incident CVD.Methods: 218 matched adult participants with and without OSA and with and without incident CVD were selected from two independent community-based prospective cohorts in France and Switzerland, and 168 microRNAs on average were detected per sample. OSA was diagnosed using the validated Berlin questionnaire in one study (Paris Prospective Study 3) and during a full-night polysomnography in the second study (HypnoLaus Study).Results: there were 78 OSA patients (39 with and 39 without CVD) and 140 controls (70 with and 70 without CVD). Participants were male in 54.6% (n 1/4 119) and mean age was 58.7 years (& PLUSMN;9.2). Of the 183 miRNAs screened, a mean 168 assays were detected per sample, and 129 in all samples. There was no pattern of blood microRNAs expression that discriminated OSA patients with and without CVD events. Conclusions: this binational study failed to find any association between a large panel of microRNAs and OSA patients with and without incident CVD.& COPY; 2023 Elsevier B.V. All rights reserved.
引用
收藏
页码:1 / 3
页数:3
相关论文
共 50 条
  • [1] Obstructive Sleep Apnea and the Risk for Cardiovascular Disease
    Puja Kohli
    Jay S. Balachandran
    Atul Malhotra
    Current Atherosclerosis Reports, 2011, 13 : 138 - 146
  • [2] Obstructive Sleep Apnea and the Risk for Cardiovascular Disease
    Kohli, Puja
    Balachandran, Jay S.
    Malhotra, Atul
    CURRENT ATHEROSCLEROSIS REPORTS, 2011, 13 (02) : 138 - 146
  • [3] Circulating adhesion molecules in obstructive sleep apnea and cardiovascular disease
    Pak, Victoria M.
    Grandner, Michael A.
    Pack, Allan I.
    SLEEP MEDICINE REVIEWS, 2014, 18 (01) : 25 - 34
  • [4] Obstructive Sleep Apnea A Risk Factor for Cardiovascular Disease
    Reishtein, Judith L.
    JOURNAL OF CARDIOVASCULAR NURSING, 2011, 26 (02) : 106 - 116
  • [5] Obstructive sleep apnea and cardiovascular risk
    Torres, Gerard
    de la Torre, Manuel Sanchez
    Pinilla, Lucia
    Barbe, Ferran
    CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS, 2024, 36 (04): : 234 - 242
  • [6] Obstructive Sleep Apnea and Cardiovascular Risk
    Kawada, Tomoyuki
    CANADIAN JOURNAL OF CARDIOLOGY, 2016, 32 (06)
  • [7] Cardiovascular risk and obstructive sleep apnea
    Bouzerda, Abdelmajid
    PAN AFRICAN MEDICAL JOURNAL, 2018, 29
  • [8] Metabolic syndrome, obstructive sleep apnea, and risk of cardiovascular disease
    Parish, James M.
    SLEEP AND BREATHING, 2012, 16 (03) : 595 - 597
  • [9] Classification of Cardiovascular Disease Risk for Patients with Obstructive Sleep Apnea
    Priyadharshini, Rameshkumar
    Pandiyan, Paulraj Muruges
    JOURNAL OF TESTING AND EVALUATION, 2023, 51 (05) : 2858 - 2878
  • [10] Metabolic syndrome, obstructive sleep apnea, and risk of cardiovascular disease
    James M. Parish
    Sleep and Breathing, 2012, 16 : 595 - 597